menu
    • menu

    Company profile for TAE Life Sciences

    NEW Drugs in Dev: 2
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in 2017, TLS is the only company developing comprehensive target drugs and neutron technology product portfolio to enable next-generation boron neutron capture therapy (BNCT) as a first-line treatment for patients globally. The company has made a significant investment in developing a portfolio of new Boron-10 target drugs, with the goal of expanding the application of BNCT to new cancer types and to provide even be...
    Founded in 2017, TLS is the only company developing comprehensive target drugs and neutron technology product portfolio to enable next-generation boron neutron capture therapy (BNCT) as a first-line treatment for patients globally. The company has made a significant investment in developing a portfolio of new Boron-10 target drugs, with the goal of expanding the application of BNCT to new cancer types and to provide even better outcomes for indications historically treated with Boronophenylalanine (BPA), the only target drug currently utilized in BNCT.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    TAE Life SciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    19631 Pauling Foothill Ranch, CA 92610
    Telephone
    Telephone
    949-830-2117
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://taelifesciences.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/tae-life-sciences/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Montpellier Institute & TAE Life Sciences Launch AMBER Project
    Montpellier Institute & TAE Life Sciences Launch AMBER Project

    17 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251217386472/en/Institut-du-Cancer-de-Montpellier-and-TAE-Life-Sciences-Launch-AMBER-Project-to-Bring-BNCT-to-France

    BUSINESSWIRE
    17 Dec 2025
    Share Share
    TAE Life BNCT Drugs + ICI Show Tumor Inhibition in Preclinical
    TAE Life BNCT Drugs + ICI Show Tumor Inhibition in Preclinical

    29 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250929560129/en/TAE-Life-Sciences-Novel-Boronated-Drugs-for-BNCT-in-Combination-with-Immune-Checkpoint-Inhibitors-Demonstrate-Superior-Tumor-Growth-Inhibition-in-Preclinical-in-vivo-Models

    BUSINESSWIRE
    29 Sep 2025
    Share Share
    TAE Life Sciences, Univ Wisconsin To Bring BNCT Cancer Treatment
    TAE Life Sciences, Univ Wisconsin To Bring BNCT Cancer Treatment

    25 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250925542671/en/TAE-Life-Sciences-and-University-of-Wisconsin-Madison-to-Bring-Promising-Accelerator-Based-BNCT-Cancer-Treatment-to-the-USA

    BUSINESSWIRE
    25 Sep 2025
    Share Share
    TAE, OSU Collaborate On Boron Drug For Cancer Therapy
    TAE, OSU Collaborate On Boron Drug For Cancer Therapy

    03 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250503894440/en/TAE-Life-Sciences-and-The-Ohio-State-University-Forge-Landmark-Collaboration-to-Advance-Boron-Drug-Innovation-for-Precision-Cancer-Therapy

    BUSINESSWIRE
    03 May 2025
    Share Share
    TAE & Kyoto Show BNCT Promise For Cancer In Preclinical Study
    TAE & Kyoto Show BNCT Promise For Cancer In Preclinical Study

    09 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250109638203/en

    BUSINESSWIRE
    09 Jan 2025
    Share Share
    TAE Life & CNAO Announce BNCT Agreement for Cancer Therapy
    TAE Life & CNAO Announce BNCT Agreement for Cancer Therapy

    17 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241217878109/en

    BUSINESSWIRE
    17 Dec 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search